Name: Mrs. VEENA GUPTA [1219056] Registration No.

: 136565
ITDOSE INFOSYSTEMS PVT. LTD.

Age/Gender: 72 Y/Female Registration Time: 09/Jul/2024 08:35AM

Patient ID: 012407090002 Collection Time: 09/Jul/2024 11:18AM
BacodeNo: 10172855 Reported: 09/Jul/2024 01:17PM
Referred By: Dr. CGHS
Report Status: Final
BIOCHEMISTRY
Test Name Result Unit Biological Ref.Interval Method

GLUCOSE FASTING (NaFluoride)

GLUCOSE FASTING, NaF plasma 161 mg/dL 70-100 GOD-POD
GLUCOSE FASTING(mg/dl):
Cord blood :45-96
Newborn 1 day:40-60
Newborn >1 day:50-80
Child :60-100

Interpretation:
ADA (American Diabetes Association) Criteria-2023

Conditions
Fasting Glucose Random Glucose
2 Hrs (75 gm)Glucose

<140 mg/dl
Normal <100 mg/dl <140 mg/dl

Prediabetes-
IGT
( Impaired 100-125 mg/dl - - - ------ --------
Fasting
Glucose )
Prediabetes (
Impaired 140-199 mg/dl or
---------- -----------
Glucose Hb A1c 5.7-6.4 %
tolerance)
>200 mg/dl or HbA1c >6.5 % >200 mg/dl
>126 mg/dl Fasting is
Diabetes The test should be performed as described by WHO, (With symptoms of
defined as no caloric
Mellitus using a glucose load containing the equivalent of 75 g Hyperglycemia or
intake for at least 8 h
anhydrous glucose dissolved in water. hyperglycemic Crisis)

Diabetes is a group of disorders associated with insufficient insulin production and/or a resistance to the effects of insulin. People with untreated diabetes are not able to
process and use glucose normally. Those who are not able to produce any or enough insulin (and typically have diabetes autoantibodies) are diagnosed as having type 1
diabetes. Those who are resistant to insulin and may or may not be able to produce sufficient quantities of it may have prediabetes or type 2 diabetes.
Factors associated with type 2 diabetes include:

Obesity
Lack of exercise
Family history of diabetes
Gestational diabetes or having a baby weighing more than 9 pounds
Polycystic ovary syndrome (PCOS)
High blood pressure

Page 1 of 4
Name: Mrs. VEENA GUPTA [1219056] Registration No.: 136565
Age/Gender: 72 Y/Female Registration Time: 09/Jul/2024 08:35AM
Patient ID: 012407090002 Collection Time: 09/Jul/2024 11:18AM
BacodeNo: 10172855 Reported: 09/Jul/2024 01:17PM
Referred By: Dr. CGHS
Report Status: Final
BIOCHEMISTRY
Test Name Result Unit Biological Ref.Interval Method

High triglyceride, high cholesterol Low HDL cholesterol

Having an A1C equal to or above 5.7% or prediabetes identified by previous testing
History of cardiovascular disease

Recommended Tests: Glucose Tests(monthly), Insulin, C-Peptide, Urine Microalbumin and Albumin/Creatinine Ratio(annually),
HbA1c (3 monthly), Creatinine Clearance, eGFR, Lipid Profile, , urine Ketones, Fructosamine( 3 weekly)

Sample Type: NaF Plasma

Kindly correlate clinically<-b>.

GLUCOSE PP (Na Fluoride)

GLUCOSE PP, NaF- Plasma 224 mg/dL 70-140 GOD-POD
GLUCOSE FASTING(mg/dl):
Cord blood :45-96
New born 1 day :40-60
New born >1 day :50-80
Child :60-100

ADA (American Diabetes Association) Criteria-2023

Conditions Fasting Glucose Random Glucose

2 Hrs (75 gm)Glucose

<140 mg/dl
Normal <100 mg/dl <140 mg/dl

Prediabetes-
IGT
( Impaired 100-125 mg/dl - - - ------ --------
Fasting
Glucose )
Prediabetes (
Impaired 140-199 mg/dl or
---------- -----------
Glucose Hb A1c 5.7-6.4 %
tolerance)

Page 2 of 4
Name: Mrs. VEENA GUPTA [1219056] Registration No.: 136565
Age/Gender: 72 Y/Female Registration Time: 09/Jul/2024 08:35AM
Patient ID: 012407090002 Collection Time: 09/Jul/2024 11:18AM
BacodeNo: 10172855 Reported: 09/Jul/2024 01:17PM
Referred By: Dr. CGHS
Report Status: Final
BIOCHEMISTRY
Test Name Result Unit Biological Ref.Interval Method

>200 mg/dl or HbA1c >6.5 % >200 mg/dl

>126 mg/dl Fasting is
Diabetes The test should be performed as described by WHO, In a patient with classic
defined as no caloric
Mellitus using a glucose load containing the equivalent of 75 symptoms ofhyperglycemia
intake for at least 8 h
g anhydrous glucose dissolved in water. or hyperglycemic crisis.

Diabetes is a group of disorders associated with insufficient insulin production and/or a resistance to the effects of insulin. People with untreated diabetes are not able to
process and use glucose normally. Those who are not able to produce any or enough insulin (and typically have diabetes autoantibodies) are diagnosed as having type 1
diabetes. Those who are resistant to insulin and may or may not be able to produce sufficient quantities of it may have prediabetes or type 2 diabetes.
Factors associated with type 2 diabetes include:

Obesity
Lack of exercise
Family history of diabetes
Gestational diabetes or having a baby weighing more than 9 pounds
Polycystic ovary syndrome (PCOS)
High blood pressure
High triglyceride, high cholesterol Low HDL cholesterol
Having an A1C equal to or above 5.7% or prediabetes identified by previous testing
History of cardiovascular disease

Recommended Tests: Glucose Tests(monthly), Insulin, C-Peptide, Urine Microalbumin and Albumin/Creatinine Ratio(annually),
HbA1c (3 monthly), , Creatinine Clearance, eGFR, Lipid Profile, , urine Ketones, Fructosamine( 3 weekly)

Sample Type: NaF Plasma

Kindly correlate clinically.<-b>

Page 3 of 4
 Name: Mrs. VEENA GUPTA [1219056] Registration No.: 136565
ITDOSE INFOSYSTEMS PVT. LTD.

Age/Gender: 72 Y/Female Registration Time: 09/Jul/2024 08:35AM

Patient ID: 012407090002 Collection Time: 09/Jul/2024 09:32AM
BacodeNo: 10172855 Reported: 09/Jul/2024 01:18PM
Referred By: Dr. CGHS
Report Status: Final
IMMUNOLOGY
Test Name Result Unit Biological Ref.Interval Method

*THYROID PROFILE,SERUM
T3 ,Serum 0.03 ug/dL 0.06-0.19 ELFA
Comment:
T3 is physiologically more active than T4 & plays an important role in maintaining euthyroidism.
T3 circulates in free form (0.3 %) and in bound form (99.7%).

T4 ,Serum 5.81 ug/dL 4.66-9.33 ELFA

Comment:
T4 is predominantly bound to carrier protein - thyroid binding globulin (TBG-99.9 %). T4 assay aids in diagnosis of hyperthyroidism - primary or
secondary hypothyroidism & thyroid hormone resistances.T4 tre must also be associated with the other tre of the thyroid assessment, such as
TSH & T3 as well as with the clinical examination to the patient.

TSH, Serum 12.03 uIU/mL 0.465-4.68 ECLIA

Pregnant Populations:
Population Units = µIU/mL (mIU/L)
1st Trimester 0.1298–3.120
2nd Trimester 0.2749–2.652
3rd Trimester 0.3127–2.947

Kindly correlate clinically.

*** End Of Report ***

Page 4 of 4